Literature DB >> 23266087

Receptor tyrosine kinase signaling mechanisms: Devolving TrkA responses with phosphoproteomics.

R A Bradshaw1, R J Chalkley, J Biarc, A L Burlingame.   

Abstract

Receptor tyrosine kinases (RTKs) function through protein kinase entities located in the intracellular domain of each protomer. Following activation by ligand binding, they selectively form phosphotyrosine residues by autocatalytic modification. Some of these sites are involved in maintaining the active conformation of the kinase, while others become docking sites for various adaptor/effector/scaffold proteins, which, after complexing with the receptor, then initiate further responses through cascades of post-translational modifications and the generation of lipid second messengers. Although there is substantial overlap in the pathways and activities stimulated by this superfamily, the molecular features of the endodomains of the sub-families and the moieties that they interact with to perpetrate their signals are surprisingly distinct, which may play a significant role in the regulation and responses of the individual RTK types. Some use large scaffold proteins as the basis for most, if not all, of their signal-generating interactions, while others have numerous receptor endodomain phosphotyrosine sites that are quite overlapping in specificity. The members of the Trk family of receptors each have several tyrosine residues that are phosphorylated following stimulation, including those in the kinase activation loop, but there are only two established sites (Y490 and Y785 on TrkA) that are known to be directly involved in signal propagation. Taking advantage of this limited repertoire of docking sites, we have applied phosphoproteomic methods to dissect the signaling responses of both the native protein and derivatives that have had these two sites modified. Interestingly, a clear subset that was not dependent on either docking site was identified. A comparison with a similar set of data for EGFR indicates a considerable degree of similarity in the downstream signaling profile between these two RTKs.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23266087      PMCID: PMC3577974          DOI: 10.1016/j.jbior.2012.10.006

Source DB:  PubMed          Journal:  Adv Biol Regul        ISSN: 2212-4926


  22 in total

Review 1.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 2.  The gift of Gab.

Authors:  Yan Liu; Larry R Rohrschneider
Journal:  FEBS Lett       Date:  2002-03-27       Impact factor: 4.124

Review 3.  Structural aspects of oligomerization taking place between the transmembrane alpha-helices of bitopic membrane proteins.

Authors:  Isaiah T Arkin
Journal:  Biochim Biophys Acta       Date:  2002-10-11

Review 4.  Oncogenic kinase signalling.

Authors:  P Blume-Jensen; T Hunter
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

5.  The induction of serine/threonine protein phosphorylations by a PDGFR/TrkA chimera in stably transfected PC12 cells.

Authors:  Jordane Biarc; Robert J Chalkley; A L Burlingame; Ralph A Bradshaw
Journal:  Mol Cell Proteomics       Date:  2011-10-25       Impact factor: 5.911

6.  FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors.

Authors:  S H Ong; G R Guy; Y R Hadari; S Laks; N Gotoh; J Schlessinger; I Lax
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

7.  The role of tyrosine residues in fibroblast growth factor receptor 1 signaling in PC12 cells. Systematic site-directed mutagenesis in the endodomain.

Authors:  E D Foehr; S Raffioni; J Murray-Rust; R A Bradshaw
Journal:  J Biol Chem       Date:  2001-07-17       Impact factor: 5.157

Review 8.  Neurotrophin signal transduction in the nervous system.

Authors:  D R Kaplan; F D Miller
Journal:  Curr Opin Neurobiol       Date:  2000-06       Impact factor: 6.627

Review 9.  Protein tyrosine kinase structure and function.

Authors:  S R Hubbard; J H Till
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

10.  Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics.

Authors:  Shao-En Ong; Blagoy Blagoev; Irina Kratchmarova; Dan Bach Kristensen; Hanno Steen; Akhilesh Pandey; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2002-05       Impact factor: 5.911

View more
  10 in total

Review 1.  NGF and ProNGF: Regulation of neuronal and neoplastic responses through receptor signaling.

Authors:  Ralph A Bradshaw; Jay Pundavela; Jordane Biarc; Robert J Chalkley; A L Burlingame; Hubert Hondermarck
Journal:  Adv Biol Regul       Date:  2014-11-20

2.  NGF signaling in PC12 cells: the cooperation of p75(NTR) with TrkA is needed for the activation of both mTORC2 and the PI3K signalling cascade.

Authors:  Sara Negrini; Rosalba D'Alessandro; Jacopo Meldolesi
Journal:  Biol Open       Date:  2013-07-12       Impact factor: 2.422

3.  Mechanisms of activation of receptor tyrosine kinases: monomers or dimers.

Authors:  Ichiro N Maruyama
Journal:  Cells       Date:  2014-04-22       Impact factor: 6.600

Review 4.  Activation of the EGF Receptor by Ligand Binding and Oncogenic Mutations: The "Rotation Model".

Authors:  Endang R Purba; Ei-Ichiro Saita; Ichiro N Maruyama
Journal:  Cells       Date:  2017-06-02       Impact factor: 6.600

5.  Merestinib (LY2801653) inhibits neurotrophic receptor kinase (NTRK) and suppresses growth of NTRK fusion bearing tumors.

Authors:  Bruce W Konicek; Andrew R Capen; Kelly M Credille; Philip J Ebert; Beverly L Falcon; Gary L Heady; Bharvin K R Patel; Victoria L Peek; Jennifer R Stephens; Julie A Stewart; Stephanie L Stout; David E Timm; Suzane L Um; Melinda D Willard; Isabella H Wulur; Yi Zeng; Yong Wang; Richard A Walgren; Sau-Chi Betty Yan
Journal:  Oncotarget       Date:  2018-02-13

6.  Neurotrophic receptor tyrosine kinase family members in secretory and non-secretory breast carcinomas.

Authors:  Athina Stravodimou; Ioannis A Voutsadakis
Journal:  World J Clin Oncol       Date:  2022-02-24

7.  Evaluation of Somatic Mutations in Solid Metastatic Pan-Cancer Patients.

Authors:  Moom R Roosan; Isa Mambetsariev; Rebecca Pharaon; Jeremy Fricke; Angel R Baroz; Joseph Chao; Chen Chen; Mohd W Nasser; Ramakanth Chirravuri-Venkata; Maneesh Jain; Lynette Smith; Susan E Yost; Karen L Reckamp; Raju Pillai; Leonidas Arvanitis; Michelle Afkhami; Edward W Wang; Vincent Chung; Mihaela Cristea; Marwan Fakih; Marianna Koczywas; Erminia Massarelli; Joanne Mortimer; Yuan Yuan; Surinder K Batra; Sumanta Pal; Ravi Salgia
Journal:  Cancers (Basel)       Date:  2021-06-03       Impact factor: 6.639

Review 8.  Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers.

Authors:  Aude I Ségaliny; Marta Tellez-Gabriel; Marie-Françoise Heymann; Dominique Heymann
Journal:  J Bone Oncol       Date:  2015-01-23       Impact factor: 4.072

9.  Trk Receptors and Neurotrophin Cross-Interactions: New Perspectives Toward Manipulating Therapeutic Side-Effects.

Authors:  Yazan Haddad; Vojtěch Adam; Zbyněk Heger
Journal:  Front Mol Neurosci       Date:  2017-05-03       Impact factor: 5.639

Review 10.  EGFRvIII: An Oncogene with Ambiguous Role.

Authors:  Adrianna Rutkowska; Ewelina Stoczyńska-Fidelus; Karolina Janik; Aneta Włodarczyk; Piotr Rieske
Journal:  J Oncol       Date:  2019-12-16       Impact factor: 4.375

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.